1. David Gortler, Felix J.V. Schlösser, Bart E. Muhs, Michael E Nelson, Alan Dardik Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence. Vasc med. 2008 Nov-Dec; 16(6): 303-9.
  2. Tiffany T Fancher, Akihito Muto, Dania Magri, David Gortler, Toshiya Nishibe and Alan Dardik Control of Blood Vessel Identity: From Embryo to Adult (COVER STORY) Ann Vasc dis Vol. 11(2008) pp.28-34
  3. Felix J.V. Schlösser, Frans L. Moll; David Gortler, Bart E. Muhs. The Promise of MR for TEVAR and EVAR: Obtaining both force and anatomic imaging and how this might affect endovascular repair. Endovasc Today March 2008, 62-67
  4. David Gortler, Stephen Maloney; Reuben Rutland, Tormod Westvik; Akihito Muto, Fabio A. Kudo, Alan Dardik. Adjunctive Pharmacologic Use in Carotid Endarterectomy: A Review Vasc med. 2006;14(2):93-102.
  5. Masae Haga, Alan Chen, David Gortler, Alan Dardik, Bauer Sumpio. Shear stress and cyclic strain may suppress apoptosis in endothelial cells by different pathways. Endothelium. 2003; 10(3): 149-57.
  6. Alan Chen, David Cortler, Sashi Kilaru, Omar Araim, Spiros Frangos, Bauer Sumpio, Cyclic strain activates the pro-survival AKT protein kinase in bovine vascular smooth muscle cells. Surgery 2001;130:378-81.
  7. Sashi Kilaru, Spiros Frangos, David Gortler, Alan Chen, Bauer Sumpio, Nicotine: a review of its role in atherogenesis. Journal of the American College of Surgeons. 2001 Nov; 1 93(5):538-46.
  8. Alan Chen, Omar Araim, Spiros Frangos, David Gortler Bauer Sumpio, Cyclic strain activates the pro-survival Akt protein kinase and BAD in bovine vascular endothelial cells Surgery
  9. Alan Chen, David Gortler, Spiros Frangos, Omar Araim, Ajay Dhadwal, Gabriel Di Luozzo, Sashi Kilaru, Bauer Sumpio, The role of cyctoskeletal integrity in cyclic strain-induced activation of MAPK. Journal of Vasc Surg

All Manuscripts, Publications, Presentations & Abstracts:

  1. All manuscripts, publications, presentations and abstracts are listed in search engines such as Google primarily under "gortler, ds" (for David S. Gortler)
  2. Additional publications may also be found under "gortler, d" "dgortler" and "ds gortler." Full list available upon request.

Clinical Research I Investigational Drug Studies:

  1. Chief Clinical Coordinator for Protocol Number 223 (SH-TPV-0005) Astra-Zeneca A Double Blind, Efficacy and Safety Study of the Oral Thrombin Inhibitor, 11376/95 versus Standard Therapy [Enoxaparin and Warfarin] in patents with Acute Symptomatic Deep Vein Thrombosis with or without Pulmonary Embolism (THRWE V)
  2. Assistant Clinical Coordinator for Protocol Number KGF-2-W1104 Human Genome Sciences A Randomized, Double Blinded, Parallel-Group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Repifermin (KGF-2) in Subjects With Venous Ulcers
  3. Assistant Clinical Coordinator for Protocol Numberl96-98-201-01 Otsuka America Pharmaceuticals Inc. A Twelve-Week Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of Three Oral Doses of OPC-28326 Versus Placebo Tablets in Patients With Intermiffent Claudication Secondary to Peripheral Arterial Disease.
  4. Assistant Clinical Coordinator for Protocol Number NAT-990133, Amgen Pharmaceuticals. Safety Pharmacokinetics and Pharmacodynamics of Novel acting Thrombolytics for initial Treatment of Chronic Peripheral Arterial Occlusion.

David Gortler

Associate Professor


  • : (203) 772-1309

  • DEPARTMENTDepartment of Pharmacology
    Georgetown University